IHS Chemical Week

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

Fresenius Kabi Increases Stake in Dabur Pharma

10:18 AM MDT | August 25, 2008 | Deepti Ramesh

Fresenius Kabi (Bad Homburg, Germany), a unit of health care group Fresenius SE, says it has completed the acquisition of Indian generics and active pharmaceutical ingredients (API) firm Dabur Pharma (New Delhi), with the purchase of a further 17.6% stake in the firm. Fresenius Kabi acquired 73.3% stake in Dabur Pharma in April for about €139 million ($224 million) (CW, April 28, p. 29). Relevant approvals required under the Indian law have also been secured, Fresenius Kabi says. Dabur Pharma is a manufacturer and supplier of generic drugs and APIs to...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa